| Michel, Gerard |
| Recruiting | 2/3 | 1800 | Europe, Canada, RoW | VP16, Etoposide, TBI, Thiotepa, Thio, Treosulfan, Treo, Fludarabine, Flu, Busulfan, Bu, ATG Thymoglobulin, ATG Thymo, Cyclophosphamide, Cy, Grafalon, Anti-human T-lymphocyte immunoglobulin | St. Anna Kinderkrebsforschung, ALL SCTped Forum, European Society for Blood and Marrow Transplantation, ALL-BFM Study Group, Assistance Publique - Hôpitaux de Paris, Dutch Childhood Oncology Group, Swiss Pediatric Oncology Group, Australian & New Zealand Children's Haematology/Oncology Group | Acute Lymphoblastic Leukaemia | 06/25 | 04/30 | | |
| GAVARET, Martine |
| Recruiting | N/A | 140 | Europe | Choice of VNS set of parameters based on the lowest PLI, EEG | Assistance Publique Hopitaux De Marseille | Epilepsy | 06/25 | 12/26 | | |
GALVANI GS-3, NCT06334952: Efficacy of Personnalized Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epileptic |
|
|
| Recruiting | N/A | 60 | Europe | transcranial direct current stimulation, Research MRI, EEG | Assistance Publique Hopitaux De Marseille, CRMBM-CEMEREM, Institut National de la Santé Et de la Recherche Médicale, France - LTSI, Neuroelectrics Corporation | Epilepsy, Drug Resistant Epilepsy | 12/26 | 11/27 | | |
| Pelletier, Jean |
| Active, not recruiting | 3 | 72 | Europe | Ocrelizumab | Centre Hospitalier Universitaire de Nice | Multiple Sclerosis | 02/26 | 02/29 | | |
STOP-I-SEP, NCT03653273: Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years |
|
|
| Recruiting | 3 | 250 | Europe | DMT withdrawal, DMT continuation | Rennes University Hospital | Multiple Sclerosis | 07/26 | 01/28 | | |
| Completed | N/A | 206 | Europe | questionnaires | Centre Hospitalier Universitaire de Nice | Multiple Sclerosis | 05/23 | 05/23 | | |
| Completed | N/A | 68 | Europe, RoW | Questionnaire | University Hospital, Bordeaux, Biogen | Multiple Sclerosis | 12/23 | 12/23 | | |
| Recruiting | N/A | 85 | Europe | inhomogeneous Magnetisation Transfer (ihMT) sequence, inhomogeneous Magnetisation Transfer (ihMT) sequence at 3T | Assistance Publique Hopitaux De Marseille | Sclerosis, Multiple | 02/26 | 02/27 | | |
NeurofilMS, NCT03981003: Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis |
|
|
| Recruiting | N/A | 1150 | Europe, RoW | Blood sample | Centre Hospitalier Universitaire de Nīmes, Hospices Civils de Lyon | Multiple Sclerosis | 06/28 | 06/28 | | |
| Recruiting | N/A | 1000 | Europe, RoW | No intervention | Hospices Civils de Lyon | Sclerosis, Multiple, Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders, Pregnancy Abnormal | 08/36 | 08/36 | | |
| BARTOLOMEI, Fabrice |
OPM, NCT04694313: Evaluation of Optical Pumping Magnetometer Sensors for MagnetoEncephaloGraphy Imaging |
|
|
| Completed | N/A | 4 | Europe | OPM | Assistance Publique Hopitaux De Marseille | Epilepsy | 12/22 | 12/22 | | |
SPREAD, NCT03321240: Study of Predictive Biomarkers for Rational Management of Drug-resistant Epilepsy Associated With Focal Cortical Dysplasia |
|
|
| Recruiting | N/A | 240 | Europe | visual and quantitative SEEG signal analysis, Resective epilepsy surgery procedure | University Hospital, Strasbourg, France | Refractory Epilepsy, Focal Epilepsy, Focal Cortical Dysplasia | 12/22 | 12/22 | | |
| Completed | N/A | 17 | Europe | transcranial direct current stimulation | Assistance Publique Hopitaux De Marseille | Epilepsy | 02/23 | 02/24 | | |
CENOR, NCT05747001: This is a Retrospective Study on the Use of CENOBAMATE as Adjunctive Treatment in Patients Suffering From Epilepsy in Early Access Program in Germany, France and UK |
|
|
| Completed | N/A | 319 | Europe | | Aziende Chimiche Riunite Angelini Francesco S.p.A, Hippocrates Research | Focal Onset Seizure, Epilepsy | 09/23 | 09/23 | | |
| Terminated | N/A | 129 | Europe | Psycho-emotional and semiological measures, Cognitive measures, Physiological measurements, Qualitative measures | Assistance Publique Hopitaux De Marseille | Epilepsy | 06/23 | 06/23 | | |
| Completed | N/A | 12 | Europe | Transcranial stimulation | Assistance Publique Hopitaux De Marseille | Epilepsy | 09/23 | 09/23 | | |
| Enrolling by invitation | N/A | 400 | Europe, Canada, Japan, US, RoW | Stereoelectroencephalography (SEEG) | Duke University, Christian Doppler University Hospital | Epilepsy Intractable | 11/25 | 11/25 | | |
| Recruiting | N/A | 240 | Europe | Multi-scale analysis of physiological brain networks | Assistance Publique Hopitaux De Marseille | Epilepsy | 04/25 | 05/25 | | |
ISEPEE, NCT06271785: Prognostic Value of High-resolution Electrical Source Imaging on the Success of Pediatric Focal Epilepsy Surgery |
|
|
| Recruiting | N/A | 120 | Europe | HR-EEG recording | University Hospital, Angers | Epilepsy in Children | 11/26 | 11/26 | | |
NCT04770337: Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy |
|
|
| Recruiting | N/A | 190 | Europe, US | STARSTIM device, Sham Device | Neuroelectrics Corporation | Refractory Epilepsy, Focal Seizure, Seizures, Focal, Seizures, Epilepsy in Children, Epilepsy, Epilepsy, Tonic-Clonic | 11/25 | 07/26 | | |
| Recruiting | N/A | 140 | Europe | Choice of VNS set of parameters based on the lowest PLI, EEG | Assistance Publique Hopitaux De Marseille | Epilepsy | 06/25 | 12/26 | | |
GALVANI GS-3, NCT06334952: Efficacy of Personnalized Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epileptic |
|
|
| Recruiting | N/A | 60 | Europe | transcranial direct current stimulation, Research MRI, EEG | Assistance Publique Hopitaux De Marseille, CRMBM-CEMEREM, Institut National de la Santé Et de la Recherche Médicale, France - LTSI, Neuroelectrics Corporation | Epilepsy, Drug Resistant Epilepsy | 12/26 | 11/27 | | |
| Azulay, Jean-Philippe |
| Recruiting | 3 | 152 | Europe | SPECT, PET | Zionexa | Parkinson Disease, Essential Tremor | 09/24 | 12/24 | | |
| Completed | 3 | 304 | Europe, US, RoW | Tavapadon, PF-06649751, CVL-751, Placebo | Cerevel Therapeutics, LLC | Parkinson Disease | 10/24 | 10/24 | | |
| Active, not recruiting | 2 | 252 | Europe, Canada, US, RoW | PTC518, Placebo | PTC Therapeutics, PTC Therapeutics, Inc. | Huntington Disease | 02/25 | 08/25 | | |
PIMPARK, NCT03947216: Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease. |
|
|
| Completed | 2 | 117 | Europe | Active drug: pimavanserin 17mg (2 strength tablets), Placebo: 2 tablets containing same excipients except active compound, Assessment of severity of ICD (impulse control disorders), Assessment of motor and non-motors symptoms of PD Evaluation of hyper- and hypodopaminergic behaviors, Assessment of quality of life, Assessment of depression, Assessment of cognition, Assessment of severity of Parkinson Disease, Blood analysis, Cardiac monitoring | University Hospital, Strasbourg, France, NS-PARK, EUCLID Clinical Trial Platform, F-CRIN, ACADIA Pharmaceuticals Inc. | Parkinson Disease | 04/24 | 06/24 | | |
RETRO-PIMPARK, NCT06754553: Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease. |
|
|
| Not yet recruiting | N/A | 100 | Europe | Assessment of severity of ICD (impulse control disorders), Assessment of motor and non-motors symptoms of PD Evaluation of hyper- and hypodopaminergic behaviors, Assessment of quality of life, Assessment of depression, Assessment of cognition, Assessment of severity of Parkinson Disease, Cardiac monitoring | University Hospital, Strasbourg, France, NS-PARK Network, EUCLID Clinical Trial Platform, F-CRIN | Parkinson Disease | 02/26 | 02/26 | | |
NCT01574053: Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort |
|
|
| Recruiting | N/A | 35000 | Europe, Canada, US, RoW | | CHDI Foundation, Inc. | Huntington's Disease | 01/62 | 01/62 | | |
| Borentain, Patrick |
| Completed | N/A | 104 | Europe | Transjugular Portosytemic Shunt (TIPS), glue obliteration | Centre Hospitalier Universitaire de Besancon | Bleeding Gastric Varices, Cirrhosis | 03/23 | 02/24 | | |
| DARIEL, Anne |
LaparoDAN, NCT04174807: Prospective Study of Antenatal Diagnostic Criteria for Digestive Complications of Gastroschisis |
|
|
| Recruiting | N/A | 200 | Europe, RoW | | University Hospital, Angers | Gastroschisis, Intestinal Occlusion | 05/22 | 05/22 | | |
AKA-NBL, NCT06798532: Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors |
|
|
| Not yet recruiting | N/A | 150 | Europe | Collection of data from the patient's medical file. | Assistance Publique - Hôpitaux de Paris | Tumor, Solid, Neuroblastic Tumors, Neuroblastoma | 09/25 | 09/25 | | |
| SIGAUDY, Delphine |
| Recruiting | N/A | 300 | Europe, RoW | Collection of blood sample or saliva, Collection of a tumor sample taken before the participation of the patient in study, Collection of blood sample if tumor sample is not available | University Hospital, Angers | Predisposition, Genetic, Cancer Childhood, Development Delay | 02/25 | 08/25 | | |
